Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of
multifactorial etiology. Most of the available drugs and FDA-approved therapies for treating …

Background: Pulmonary arterial hypertension (PAH) is a debilitating chronic disorder of the
pulmonary vasculature characterized by elevated mean pulmonary arterial pressure, right …

Pulmonary arterial hypertension (PAH) is a disease in which stenosis or obstruction of the
pulmonary arteries (PAs) causes an increase in PA pressure, leading to right-sided heart …

Pulmonary arterial hypertension (PAH) is a life-threatening and progressive disease of
various origins characterized by pulmonary vascular remodeling that leads to increased …

Pulmonary arterial hypertension (PAH) is a chronic disease that results in narrowing of the
small pre-capillary pulmonary arteries leading to elevation of pulmonary artery pressure and …

Abstract Purpose of Review This review focuses on the therapeutic management and
individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food …

Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction, in situ
thrombosis, and vascular remodeling of small pulmonary arteries inducing increased …

Pulmonary arterial hypertension (PAH) develops from an abnormal interaction between the
endothelium and smooth muscle cells in the pulmonary vasculature and is characterized by …

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Pulmonary arterial hypertension (PAH) is a fatal disease associated with vasoconstriction
and vascular remodelling. There are three well-known pathways that contribute to the …